Effect of Tong-Xie-Yao-Fang in the Treatment of CD in remission with Liver Depression and Spleen Deficiency during IFX treatment
Phase 1
- Conditions
- Crohn disease
- Registration Number
- ITMCTR2100005041
- Lead Sponsor
- First Affiliated Hospital of Zhejiang Chinese Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. CD patients have a clinical response in the 10th week after completing IFX induction therapy (?CDAI>=70 points compared with the baseline period of treatment);
2. IFX treatment course >= 1 year;
3. Clinical remission in the 14th week after IFX induction therapy (CDAI<150 points);
4. No severe cardiac insufficiency, no severe pulmonary dysfunction, and basically normal liver and kidney functions.
Exclusion Criteria
1. Combined nutritional therapy and hormone therapy;
2. Those with other major internal diseases such as respiratory, digestive, blood, cardiovascular, and endocrine diseases.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptom score;
- Secondary Outcome Measures
Name Time Method